A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes

Clinical trial NCT04747431 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04747431
Sponsor: Passage Bio, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Frontotemporal Dementia FTD FTD-GRN Dementia Frontotemporal C9orf72

Start date: 2021-09-14
Primary completion: 2028-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.